Spatial single-cell analysis of somatic mutation in human brain during aging and neurodegeneration
Spatial single-cell analysis of somatic mutation in human brain during aging and neurodegeneration
批准号:
10687449
负责人:
Michael Anthony Lodato
金额:
$150.75万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-15 至 2026-08-31
关键词:
AccelerationAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease related dementiaAmyloid beta-ProteinAwardBrainCellsCockayne SyndromeDNA DamageDNA Repair GeneDNA analysisDNA sequencingDiseaseGenesGeneticGenomeGenomicsGoalsHumanHuman DevelopmentHuman bodyMalignant NeoplasmsMethodsMutationNerve DegenerationNeurodegenerative DisordersNeurofibrillary TanglesNeuronsNoiseParkinson DiseasePathologicPathway interactionsPatternProcessResolutionSkeletal MuscleSomatic MutationTestingWorkXeroderma Pigmentosumage relatedage related neurodegenerationassaultbrain celldisease-causing mutationearly onsetexperienceexperimental studygenome integritygenome sequencinghuman diseasemisfolded proteinneuron lossnormal agingoxidative DNA damagepostmitoticpresenilin-1presenilin-2protein aggregationrepairedsingle cell analysistau Proteinstau aggregationwhole genome
中文摘要
阿尔茨海默病和相关的痴呆症表现出与年龄相关的发病,错误折叠的蛋白质聚集体,如β-淀粉样蛋白和tau缠结,氧化DNA损伤增加,最终导致神经元细胞死亡。由DNA修复基因突变引起的孟德尔类早老性疾病表现出类似阿尔茨海默氏症的早发性神经变性,这表明基因组完整性受损可以加速衰老并直接导致神经元损失。DNA损伤可以修复,但可能导致称为体细胞突变的基因组的永久性变化,导致体细胞突变负担增加可能在与年龄相关的神经退行性疾病中很常见的假设。在阿尔茨海默病的大脑中,对这一假设的直接支持仍然是难以捉摸的,因为标准的dna测序实验不足以全面表征有丝分裂后人类神经元中发生的体细胞突变。这样的实验力量不足,因为有丝分裂后神经元中发生的突变只存在于发生突变的单个细胞中,因此在分析从数百万个脑细胞中分离出来的DNA时,无法将其与背景噪声区分开来。
英文摘要
Alzheimer’s disease and related dementias display an age-related onset, misfolded protein aggregates such as β-amyloid and tau tangles, increased oxidative DNA damage, and ultimately neuron cell death. Mendelian progeroid diseases caused by mutations in DNA repair genes show early-onset neurodegeneration resembling Alzheimer’s, suggesting that compromised genomic integrity can accelerate aging and directly cause neuron loss. DNA damage can be repaired but may result in permanent changes to the genome called somatic mutations, leading to the hypothesis that increased somatic mutation burden may be common across age-related neurodegenerative disorders. Direct support for this hypothesis has remained elusive in the Alzheimer’s disease brain because standard DNA-sequencing experiments are underpowered to characterize somatic mutations that occur in postmitotic human neurons comprehensively. Such experiments are underpowered because a mutation arising in a postmitotic neuron would be unique to only the single cell in which it occurred and thus it would be indistinguishable from background noise when analyzing DNA isolated from millions of brain cells.
We recently developed methods to study somatic mutations in human neurons at single-cell resolution, including methods for single-cell, whole genome sequencing (scWGS). We used scWGS to show that permanent somatic mutations accompany aging in human neurons, with specific mutation signatures nominating discrete pathways generating DNA damage in the human brain. Mutation counts and signatures differ in neurons from donors with genetic early-onset neurodegenerative diseases, specifically Cockayne syndrome and Xeroderma Pigmentosum, and in the late-onset sporadic Alzheimer’s donors, suggesting neurodegeneration is associated with specific patterns of somatic mutation. We found no evidence for mutational hotspots in known Alzheimer’s genes such as APOE, PSEN1, PSEN2, or APP, instead finding that somatic mutations in Alzheimer’s neurons represent a stochastic assault on the genome in each cell.
The goal of this New Innovator Award proposal is to develop and apply new scWGS methods to study somatic mutations during neurodegeneration in unprecedented detail. We will focus on neurons from late-stage Alzheimer’s disease donors and from donors with late-stage Parkinson’s disease, another age-associated neurodegenerative disorder characterized by increased DNA damage, aggregates of misfolded protein, and neuron cell death. We will focus on those neurons with known pathological hallmarks of these diseases, for example, β-amyloid and tau aggregates, to test the hypothesis that these neurons experience increased DNA damage and thus increased somatic mutations. This work will have broad impacts in the fields of single-cell genomics, aging, neurodegeneration, and human development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Single-cell analysis of DNA damage, somatic mutation, and gene expression in human Alzheimer’s disease brain
-
批准号:10901006
-
项目类别:
-
资助金额:$83.58万
-
财政年份:2023
-
负责人:Michael Anthony Lodato
-
依托单位:
Analysis of pathogenic mosaic mutations in human Amyotrophic Lateral Sclerosis nervous system
-
批准号:10576017
-
项目类别:
-
资助金额:$46.06万
-
财政年份:2022
-
负责人:Michael Anthony Lodato
-
依托单位:
SINGLE-CELL ANALYSIS OF SOMATIC MUTATION IN AGING AND NEUROEGENERATIVE DISEASE IN THE HUMAN BRAIN
-
批准号:10006779
-
项目类别:
-
资助金额:$24.79万
-
财政年份:2017
-
负责人:Michael Anthony Lodato
-
依托单位:
SINGLE-CELL ANALYSIS OF SOMATIC MUTATION IN AGING ANO NEUROOEGENERATIVE DISEASE IN THE HUMAN BRAIN
-
批准号:10237914
-
项目类别:
-
资助金额:$24.58万
-
财政年份:2017
-
负责人:Michael Anthony Lodato
-
依托单位:
Analysis of somatic mutations in the aging human brain using single-cell whole genome sequencing
-
批准号:9044918
-
项目类别:
-
资助金额:$5.6万
-
财政年份:2015
-
负责人:Michael Anthony Lodato
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: